Poll: Most Americans believe new Alzheimer’s drug is effective, but many are concerned with FDA process

Biogen biotechnology headquarters seen in Cambridge, Massachusetts, on Oct. 5, 2018. (Ruby Wallau for STAT)

By Ed Silverman | STAT News | June 18, 2021

Two-thirds of Americans who are familiar with the details of the newly approved Alzheimer’s treatment believe the medication will be effective, but have concerns about the regulatory process used to endorse the drug and are divided over whether the drug is fairly priced at $56,000 a year, according to a new survey from STAT and The Harris Poll.

Read the full story at STAT News.